US7964571B2
(en)
|
2004-12-09 |
2011-06-21 |
Egen, Inc. |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
DK2730277T3
(da)
|
2004-12-22 |
2020-04-06 |
Nitto Denko Corp |
Lægemiddelbærer og lægemiddelbærerkit til at inhibere fibrose
|
DE102005039154A1
(de)
*
|
2005-08-17 |
2007-03-01 |
GÖPFERICH, Achim, Prof. Dr. |
Bioabbaubare Polymere für den Transport von Nukleinsäuren in Zellen
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
KR100825519B1
(ko)
*
|
2007-01-05 |
2008-04-25 |
주식회사 바이오폴리메드 |
키토산 기재 고분자 접합체 및 그 제조방법
|
JP5615558B2
(ja)
*
|
2007-02-28 |
2014-10-29 |
セリナ・セラピユーテイツクス・インコーポレーテツド |
活性ポリオキサゾリンおよびそれを含む組成物
|
TWI407971B
(zh)
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
WO2009009441A2
(en)
|
2007-07-06 |
2009-01-15 |
Cedars-Sinai Medical Center |
Self-assembling complex for targeting chemical agents to cells
|
US9144546B2
(en)
|
2007-08-06 |
2015-09-29 |
Clsn Laboratories, Inc. |
Nucleic acid-lipopolymer compositions
|
WO2009036368A2
(en)
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
US20090130752A1
(en)
*
|
2007-11-07 |
2009-05-21 |
University Of Utah Research Foundation |
Biodegradable poly(disulfide amine)s for gene delivery
|
BRPI0820302A2
(pt)
*
|
2007-11-09 |
2015-05-19 |
Univ Northeastern |
Nanopartículas semelhantes a micelas de automontagem para liberação sistêmica de gene
|
US20090171455A1
(en)
*
|
2007-12-31 |
2009-07-02 |
Boston Scientific Scimed, Inc. |
Biodegradable polymers
|
DK3042922T3
(en)
*
|
2008-01-11 |
2017-10-23 |
Serina Therapeutics Inc |
MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COLPOLYMERS AND PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME
|
FR2928373B1
(fr)
*
|
2008-03-05 |
2010-12-31 |
Centre Nat Rech Scient |
Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
|
AU2009223313A1
(en)
*
|
2008-03-14 |
2009-09-17 |
Egen, Inc. |
Biodegradable cross-linked branched poly (alkylene imines)
|
JP5788312B2
(ja)
*
|
2008-04-11 |
2015-09-30 |
アルニラム ファーマスーティカルズ インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
標的リガンドをエンドソーム分解性成分と組み合わせることによる核酸の部位特異的送達
|
WO2010085665A2
(en)
|
2009-01-23 |
2010-07-29 |
Cedars-Sinai Medical Center |
Targeted delivery system
|
KR101132413B1
(ko)
*
|
2009-05-06 |
2012-04-03 |
서울대학교산학협력단 |
Sars 백신 나노전달체
|
CN101585921B
(zh)
*
|
2009-06-18 |
2010-12-01 |
天津大学 |
温度敏感聚乙烯亚胺-接枝-聚丙烯酸寡乙二醇酯嵌段共聚物及制备方法和应用
|
CN102575204B
(zh)
*
|
2009-10-23 |
2015-02-25 |
荷兰联合利华有限公司 |
染料聚合物
|
CN101812178B
(zh)
*
|
2010-04-20 |
2012-07-04 |
武汉大学 |
还原敏感性聚乙烯亚胺衍生物及其制备方法和应用
|
EP2569406A4
(en)
*
|
2010-05-14 |
2013-11-13 |
Sun Products Corp |
POLYMERIC CLEANING COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE
|
WO2011162366A1
(ja)
*
|
2010-06-25 |
2011-12-29 |
東レ株式会社 |
水溶性ポリマー及び水溶性ナノ粒子複合体
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
CN104531812A
(zh)
|
2010-10-01 |
2015-04-22 |
现代治疗公司 |
设计核酸及其使用方法
|
CN102174184B
(zh)
*
|
2011-01-14 |
2012-11-21 |
中国科学院广州生物医药与健康研究院 |
一种生物可降解的聚合物及其制备方法以及核酸药物运输载体
|
WO2012135805A2
(en)
|
2011-03-31 |
2012-10-04 |
modeRNA Therapeutics |
Delivery and formulation of engineered nucleic acids
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
US20130071444A1
(en)
|
2011-09-16 |
2013-03-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Amphiphilic Cationic Polymers and Methods of Use Thereof
|
RU2707251C2
(ru)
|
2011-10-03 |
2019-11-25 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
WO2013151666A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
EP2833892A4
(en)
|
2012-04-02 |
2016-07-20 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS AND PEPTIDES ASSOCIATED WITH ONCOLOGY
|
US20130337067A1
(en)
|
2012-06-15 |
2013-12-19 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Non-viral nanoparticle-based delivery system
|
ES2703052T3
(es)
|
2012-08-03 |
2019-03-06 |
Cedars Sinai Medical Center |
Aislamiento de mutantes potenciadores del tráfico de proteína de entrega de fármacos
|
CN103305549B
(zh)
*
|
2013-06-19 |
2015-04-22 |
四川大学 |
具有多重氧化还原刺激响应的纳米粒子基因载体系统及其制备方法和应用
|
WO2014056414A1
(zh)
|
2012-10-10 |
2014-04-17 |
四川大学 |
一种还原刺激响应型基因载体系统及其制备和应用
|
KR101452819B1
(ko)
|
2012-11-01 |
2014-10-23 |
국립암센터 |
환원제 반응형 이황화물 연결자 함유 고분자-광감각제 결합체 및 이를 포함하는 형광 영상 진단 및 광역학 치료용 조성물
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
化学修飾mRNA
|
JP2016504050A
(ja)
|
2013-01-17 |
2016-02-12 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
細胞表現型の改変のためのシグナルセンサーポリヌクレオチド
|
WO2014159813A1
(en)
|
2013-03-13 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
WO2014152211A1
(en)
|
2013-03-14 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
EP3971287A1
(en)
|
2013-07-11 |
2022-03-23 |
ModernaTX, Inc. |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
AU2014315287A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
US10323076B2
(en)
|
2013-10-03 |
2019-06-18 |
Modernatx, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
JP2017500865A
(ja)
|
2013-12-19 |
2017-01-12 |
ノバルティス アーゲー |
レプチンmRNAの組成物および製剤
|
MX2016009284A
(es)
|
2014-01-17 |
2016-10-07 |
Cedars Sinai Medical Center |
Construcciones dirigidas a receptor y sus usos.
|
MX2016013025A
(es)
|
2014-04-04 |
2017-04-27 |
Cedars Sinai Medical Center |
Focalizacion de cancer de mama her2+ resistente a trastuzumab con una nanoparticula dirigida de her3.
|
CN104109248B
(zh)
*
|
2014-06-20 |
2017-02-01 |
南开大学 |
基于桥式双环糊精主客体诱导聚集构筑的聚集体及其应用
|
CA2955250A1
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
US20170210788A1
(en)
|
2014-07-23 |
2017-07-27 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
CN104356395B
(zh)
*
|
2014-11-12 |
2016-08-17 |
苏州大学 |
一种阳离子化丝素蛋白、制备方法及其应用
|
US10709791B2
(en)
|
2014-11-12 |
2020-07-14 |
University Of Washington |
Stabilized polymeric carriers for therapeutic agent delivery
|
CN105012957B
(zh)
*
|
2015-07-03 |
2019-03-22 |
上海交通大学 |
一种交联型聚乙烯亚胺作为肿瘤蛋白抗原疫苗载体的用途
|
WO2017049209A1
(en)
*
|
2015-09-16 |
2017-03-23 |
University Of Utah Research Foundation |
A polymeric carrier for delivery of a payload to a cell
|
DE102017003004A1
(de)
*
|
2017-03-23 |
2018-09-27 |
Friedrich-Schiller-Universität Jena |
Kationische Polymere mit D-Fructose-Substituenten
|
CA3063723A1
(en)
|
2017-05-18 |
2018-11-22 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (il12) polypeptides and uses thereof
|
WO2018213789A1
(en)
|
2017-05-18 |
2018-11-22 |
Modernatx, Inc. |
Modified messenger rna comprising functional rna elements
|
US20200268666A1
(en)
|
2017-06-14 |
2020-08-27 |
Modernatx, Inc. |
Polynucleotides encoding coagulation factor viii
|
EP4219715A3
(en)
|
2017-09-08 |
2023-09-06 |
MiNA Therapeutics Limited |
Stabilized cebpa sarna compositions and methods of use
|
CA3079543A1
(en)
|
2017-11-22 |
2019-05-31 |
Modernatx, Inc. |
Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia
|
EP3714047A2
(en)
|
2017-11-22 |
2020-09-30 |
ModernaTX, Inc. |
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
|
EP3714048A1
(en)
|
2017-11-22 |
2020-09-30 |
Modernatx, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
WO2019136241A1
(en)
|
2018-01-05 |
2019-07-11 |
Modernatx, Inc. |
Polynucleotides encoding anti-chikungunya virus antibodies
|
US11193000B2
(en)
|
2018-02-27 |
2021-12-07 |
Soochow University |
Reversible self-repairing epoxy resin and preparation and recovery remoulding method therefor
|
EP3775211B1
(en)
|
2018-04-12 |
2023-04-05 |
MiNA Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
US20210148918A1
(en)
*
|
2018-04-17 |
2021-05-20 |
Purdue Research Foundation |
Modifying surface of a live cell and the uses thereof
|
KR101992236B1
(ko)
|
2018-05-16 |
2019-06-24 |
가톨릭대학교 산학협력단 |
디셀레노디프로피오네이트의 양 말단에 폴리(입실론-카프로락톤)이 공유결합된 환원분해성 폴리(입실론-카프로락톤) 고분자, 이를 포함하는 항암용 조성물 및 약물 전달용 조성물
|
WO2019226650A1
(en)
|
2018-05-23 |
2019-11-28 |
Modernatx, Inc. |
Delivery of dna
|
WO2020023390A1
(en)
|
2018-07-25 |
2020-01-30 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
EP3833762A4
(en)
|
2018-08-09 |
2022-09-28 |
Verseau Therapeutics, Inc. |
OLIGONUCLEOTIDE COMPOSITIONS FOR TARGETING CCR2 AND CSF1R AND THEIR USES
|
CN110859969B
(zh)
*
|
2018-08-28 |
2022-01-11 |
上海市第十人民医院 |
聚乙烯亚胺修饰的荧光素钠造影剂及其制备方法和应用
|
MA53545A
(fr)
|
2018-09-02 |
2021-07-14 |
Modernatx Inc |
Polynucléotides codant pour l'acyl-coa déshydrogénase à très longue chaîne pour le traitement de l'insuffisance en acyl-coa déshydrogénase à très longue chaîne
|
JP2022500436A
(ja)
|
2018-09-13 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
糖原病を処置するためのグルコース−6−ホスファターゼをコードするポリヌクレオチド
|
WO2020056155A2
(en)
|
2018-09-13 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease
|
JP2022500444A
(ja)
|
2018-09-14 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
クリグラー−ナジャー症候群の治療のためのウリジン二リン酸グリコシルトランスフェラーゼ1ファミリー、ポリペプチドa1をコードするポリヌクレオチド
|
MA53734A
(fr)
|
2018-09-27 |
2021-08-04 |
Modernatx Inc |
Polynucléotides codant pour l'arginase 1 pour le traitement d'une déficience en arginase
|
WO2020208361A1
(en)
|
2019-04-12 |
2020-10-15 |
Mina Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
WO2020227642A1
(en)
|
2019-05-08 |
2020-11-12 |
Modernatx, Inc. |
Compositions for skin and wounds and methods of use thereof
|
WO2021247507A1
(en)
|
2020-06-01 |
2021-12-09 |
Modernatx, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
EP4243776A1
(en)
|
2020-11-13 |
2023-09-20 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
WO2022204390A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
WO2022204380A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
WO2022204369A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
US20240207374A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
US20240189449A1
(en)
|
2021-03-24 |
2024-06-13 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
|
KR20230160872A
(ko)
|
2021-03-26 |
2023-11-24 |
미나 테라퓨틱스 리미티드 |
Tmem173 sarna 조성물 및 사용 방법
|
EP4355882A2
(en)
|
2021-06-15 |
2024-04-24 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
WO2022271776A1
(en)
|
2021-06-22 |
2022-12-29 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
WO2023056044A1
(en)
|
2021-10-01 |
2023-04-06 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
WO2023099884A1
(en)
|
2021-12-01 |
2023-06-08 |
Mina Therapeutics Limited |
Pax6 sarna compositions and methods of use
|
WO2023170435A1
(en)
|
2022-03-07 |
2023-09-14 |
Mina Therapeutics Limited |
Il10 sarna compositions and methods of use
|
WO2023183909A2
(en)
|
2022-03-25 |
2023-09-28 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
CN114920859B
(zh)
*
|
2022-05-11 |
2023-09-26 |
宁夏医科大学总医院 |
5-氟尿嘧啶-1-丁酰基-β-环糊精第二面衍生物及制备方法及其应用
|
WO2024026254A1
(en)
|
2022-07-26 |
2024-02-01 |
Modernatx, Inc. |
Engineered polynucleotides for temporal control of expression
|
WO2024103225A1
(zh)
*
|
2022-11-14 |
2024-05-23 |
林桂孜 |
一种阳离子聚酯及其制备方法和应用
|